Zinzino's total revenues for the third quarter of 2018 amounted to 139.2 (120.1) MSEK, corresponding to sales growth of 16% compared to the third quarter 2017.
Accumulated for January - September 2018, total revenues amounted to 421.1 (385.6) MSEK, corresponding to an increase of 9% compared with the previous year.
"We see strong sales growth in many markets driven by our dedicated distributors and the digital shift we carry out," concludes Dag Bergheim Petersen, CEO Zinzino.
For more information:
Dag Bergheim Pettersen, CEO Zinzino, Mobile: +47 (0) 93 22 57 00 www.zinzino.com 
Pictures for publication free of charge:
Marcus Tollbom, Mobile: +46 (0) 70 190 03 12 
Certified Adviser: Erik Penser Bank Aktiebolag 
Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 13:00 the 11th of October, 2018. 
Zinzino AB (publ.) is a direct sales company that operates throughout Europe and North America. Zinzino markets and sells products in two product lines: Zinzino Health, with a focus on long-term health, and Zinzino Coffee, consisting of espresso machines, coffee and tea. Zinzino owns the Norwegian company BioActive Foods AS and the research and production unit Faun Pharma AS. Zinzino has more than 120 employees and currently trades in 33 markets across Europe and North America. Zinzino is based in Gothenburg, with additional offices in Helsinki, Riga, Oslo, and in Florida, USA. Zinzino is a public company and its shares are listed on Nasdaq First North. In 2016, Zinzino was recognized with the award `'Superföretag 2015'' by Veckans Affärer and the `'Gazelle'' award by Dagens Industri.